These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26536)

  • 21. Prediction of human pharmacokinetics--gut-wall metabolism.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1335-43. PubMed ID: 17910807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug metabolism in the small intestine--the significance for biological availability].
    Andersen VC; Sonne J
    Ugeskr Laeger; 2000 May; 162(22):3215-9. PubMed ID: 10850220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presystemic extraction: mechanisms and consequences.
    Greenblatt DJ
    J Clin Pharmacol; 1993 Jul; 33(7):650-6. PubMed ID: 8366190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique.
    von Richter O; Greiner B; Fromm MF; Fraser R; Omari T; Barclay ML; Dent J; Somogyi AA; Eichelbaum M
    Clin Pharmacol Ther; 2001 Sep; 70(3):217-27. PubMed ID: 11557909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Calculation of different pharmacokinetic parameters from plasma data for a bicompartmental model of first order oral absorption].
    Fredj G; Clenet M; Rousselet F
    Therapie; 1978; 33(1):133-6. PubMed ID: 663893
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatic vs. gastrointestinal presystemic extraction of oral midazolam and flurazepam.
    Ochs HR; Greenblatt DJ; Eichelkraut W; Bakker C; Göbel R; Hahn N
    J Pharmacol Exp Ther; 1987 Dec; 243(3):852-6. PubMed ID: 3694534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A technique to study hepatic and intestinal drug metabolism separately in the dog.
    Effeney DJ; Pond SM; Lo MW; Silber BM; Riegelman S
    J Pharmacol Exp Ther; 1982 May; 221(2):507-11. PubMed ID: 7077540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in pentobarbital pharmacokinetics in response to parenteral and enteral alimentation in the rat.
    Knodell RG; Spector MH; Brooks DA; Keller FX; Kyner WT
    Gastroenterology; 1980 Dec; 79(6):1211-6. PubMed ID: 6777235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The area under the curve of metabolites for drugs and metabolites cleared by the liver and extrahepatic organs. Its dependence on the administration route of precursor drug.
    Klippert PJ; Noordhoek J
    Drug Metab Dispos; 1985; 13(1):97-101. PubMed ID: 2858385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the deconvolution principle in the estimation of absorption and pre-systemic intestinal elimination of drugs.
    Pithavala YK; Soria I; Zimmerman CL
    Drug Metab Dispos; 1997 Nov; 25(11):1260-5. PubMed ID: 9351902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications.
    Cho HJ; Kim JE; Kim DD; Yoon IS
    Drug Dev Ind Pharm; 2014 Aug; 40(8):989-98. PubMed ID: 23981203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why we need proper PBPK models to examine intestine and liver oral drug absorption.
    Chow EC; Pang KS
    Curr Drug Metab; 2013 Jan; 14(1):57-79. PubMed ID: 22935069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oral bioavailability and drug/carrier particulate systems].
    Wawrezinieck A; Péan JM; Wüthrich P; Benoit JP
    Med Sci (Paris); 2008; 24(6-7):659-64. PubMed ID: 18601886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental models for predicting drug absorption and metabolism.
    Alqahtani S; Mohamed LA; Kaddoumi A
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1241-54. PubMed ID: 23687990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the intestinal permeability and first-pass metabolism of drugs in cynomolgus monkeys using single-pass intestinal perfusion.
    Takahashi M; Washio T; Suzuki N; Igeta K; Yamashita S
    Biol Pharm Bull; 2010; 33(1):111-6. PubMed ID: 20045946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of gastrointestinal motility directly from human pharmacokinetic data.
    Roush JA
    Int J Pharm; 2011 Oct; 419(1-2):43-51. PubMed ID: 21784142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism.
    Pang KS; Gillette JR
    J Pharm Sci; 1978 May; 67(5):703-4. PubMed ID: 641815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Theoretical consideration of the properties of intestinal flow models on route-dependent drug removal: Segregated Flow (SFM) vs. Traditional (TM).
    Noh K; Pang KS
    Biopharm Drug Dispos; 2019 May; 40(5-6):195-213. PubMed ID: 31099032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism.
    Zhang Z; Gao F; Jiang S; Ma L; Li Y
    Curr Drug Metab; 2012 Oct; 13(8):1110-8. PubMed ID: 22380010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First-pass elimination. Basic concepts and clinical consequences.
    Pond SM; Tozer TN
    Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.